SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001571049-14-004542
Filing Date
2014-09-11
Accepted
2014-09-11 16:23:13
Documents
5
Group Members
DANIEL J. DONOGHUEDISCOVERY EQUITY PARTNERS, L.P.MICHAEL R. MURPHY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D (AMENDMENT NO. 1) t80258_sc13da.htm SC 13D/A 140834
2 EXHIBIT 1 ex1.htm EX-1 16898
3 EXHIBIT 2 ex2.htm EX-2 10637
4 EXHIBIT 3 ex3.htm EX-3 9034
5 EXHIBIT 4 ex4.htm EX-4 8914
  Complete submission text file 0001571049-14-004542.txt   187854
Mailing Address 191 N. WACKER DRIVE SUITE 1685 CHICAGO IL 60606
Business Address 191 N. WACKER DRIVE SUITE 1685 CHICAGO IL 60606 (312) 265-96000
Discovery Group I, LLC (Filed by) CIK: 0001312548 (see all company filings)

IRS No.: 300075077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Subject) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A | Act: 34 | File No.: 005-86843 | Film No.: 141098369
SIC: 2834 Pharmaceutical Preparations